Jul. 31 2025
Source Page: Independent Patient Choice and Procurement Panel: case acceptance decision in relation to a proposed contract award for mental health support services in West SussexJul. 31 2025
Source Page: GP contract 2025/26 financial information – mid-year updatesJul. 31 2025
Source Page: Overweight and obesity managementJul. 30 2025
Source Page: Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and overJul. 30 2025
Source Page: Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosisJul. 30 2025
Source Page: Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and overJul. 30 2025
Source Page: Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and overJul. 30 2025
Source Page: Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and overJul. 30 2025
Source Page: Vanzacaftor-tezacaftor-deutivacaftor for treating cystic fibrosis with 1 or more F508del mutations in the CFTR gene in people 6 years and overJul. 30 2025
Source Page: Emicizumab for prophylaxis of bleeding episodes in people with moderate haemophilia A without inhibitors